Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New screening system aims to catch hidden heart damage after surgery

NCT ID NCT05859620

First seen May 13, 2026 · Last updated Jun 22, 2026 · Updated 5 times

Summary

This study looks at whether a new screening system can help doctors find heart complications early in high-risk patients after noncardiac surgery. Researchers will track 900 patients to see how well the screening works in practice and what it costs. The goal is to gather information for a future larger trial, not to test a new drug or treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYOCARDIAL INFARCTION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Bürgerspital Solothurn

    Solothurn, 4500, Switzerland

  • Canton Hospital Olten

    Olten, Canton of Solothurn, 4600, Switzerland

  • Cantonal Hospital Lucerne

    Lucerne, Canton of Lucerne, 6000, Switzerland

  • University Hospital Geneva

    Geneva, Canton of Geneva, 1205, Switzerland

  • University Hospital Innsbruck

    Innsbruck, Tyrol, 6020, Austria

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to a standard screening system that catches heart problems early after surgery, potentially improving patient outcomes and reducing costs.

What could go wrong

This is an observational study, not testing a new treatment. It only measures feasibility and costs, so it won't directly prove that screening saves lives or prevents complications.

Conditions

The condition(s) this trial relates to.

myocardial infarction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.